Abstract. Understanding the tumor microenvironment is critical to characterizing how cancers operate and predicting their response to treatment. We describe a novel, high-resolution coregistered photoacoustic (PA) and pulse echo (PE) ultrasound system used to image the tumor microenvironment. Compared to traditional optical systems, the platform provides complementary contrast and important depth information. Three mice are implanted with a dorsal skin flap window chamber and injected with PC-3 prostate tumor cells transfected with green fluorescent protein. The ensuing tumor invasion is mapped during three weeks or more using simultaneous PA and PE imaging at 25 MHz, combined with optical and fluorescent techniques. Pulse echo imaging provides details of tumor structure and the surrounding environment with 100-μm 3 resolution. Tumor size increases dramatically with an average volumetric growth rate of 5.35 mm 3 /day, correlating well with 2-D fluorescent imaging (R = 0.97, p < 0.01). Photoacoustic imaging is able to track the underlying vascular network and identify hemorrhaging, while PA spectroscopy helps classify blood vessels according to their optical absorption spectrum, suggesting variation in blood oxygen saturation. Photoacoustic and PE imaging are safe, translational modalities that provide enhanced depth resolution and complementary contrast to track the tumor microenvironment, evaluate new cancer therapies, and develop molecular contrast agents in vivo. C 2011 Society of Photo-Optical Instrumentation Engineers (SPIE).
Introduction
Prostate cancer is an aggressive disease that has high morbidity and mortality rates and is the most commonly diagnosed invasive cancer among men. 1, 2 The American Cancer Society estimated that in the United States in 2010 over 215,000 cases would be diagnosed and that over 30,000 men would die of the disease. 3 The current gold standard for prostate cancer detection involves an invasive biopsy, a procedure that contributes to patient discomfort and can have medical complications, such as hemorrhage and infection. 4 Early diagnosis through improved detection would aid in the intervention and treatment of the disease.
The dorsal skin flap window chamber is a well-established model employed in preclinical cancer research. The window chamber facilitates longitudinal studies designed to monitor the tumor microenvironment, track growth, and assess the effects of therapy. 5 It is also compatible with multiple modalities, including fluorescent microscopy, [6] [7] [8] nuclear imaging, 9 magnetic resonance, [10] [11] [12] [13] electrode imaging, 14 biological polarimetry, 15 pH mapping, 16, 17 and computed tomography. 18 However, each of these techniques has limitations related to invasiveness, source of contrast, penetration depth, sensitivity, and/or spatial resolution. To complement existing approaches for studying the tumor environment, we developed a novel in vivo platform capable of simultaneous photoacoustic (PA) and pulse echo (PE) imaging of cancer using the mouse window chamber model. In PA imaging, the tissue is illuminated with light, typically in the form of a high-energy pulsed laser. As light penetrates, energy is partially absorbed and converted to heat, causing rapid thermoelastic expansion and generation of ultrasound waves, which are detected to form an ultrasound image. 19 With diffuse illumination, PA imaging provides spatial resolution proportional to the ultrasound wavelength with contrast related to the local optical absorption. Compared to most optical techniques, PA imaging exhibits deeper penetration. 20 Because of the relatively high optical absorption coefficient of hemoglobin, this approach is excellent for characterizing the tumor vasculature and has great potential for noninvasive cancer detection and characterization. Photoacoustic spectroscopy provides additional contrast for identifying different types of tissue and blood vessels based on variations in their optical absorption spectra. 21 On the other hand, PE ultrasound is a well-established technique commonly used for clinical prostate cancer imaging. [22] [23] [24] [25] It provides highresolution anatomical detail related to tissue structure and tumor size. Our imaging platform was designed to simultaneously capture PA and PE signals, producing a dual modality imaging system with contrast related to tumor structure, size, and vasculature. This system is an important enhancement to the window chamber model for monitoring the tumor microenvironment and aiding in the development of novel contrast agents and cancer therapeutics. 26 Finally, dual-modality PA and PE imaging are translational techniques that potentially impact cancer patients, offering complementary contrast and better depth penetration compared to most optical techniques. Fig. 1 Photographs of window chamber from mouse R1 on day 9 postimplantation: (a) Photograph from coverslip side and (b) photograph (mirror image) from skin side. The three screws on the chamber were used to secure the window chamber to the imaging apparatus. The arrows denote the fiducial ink mark placed on the skin. The window chamber had a diameter of 12 mm. (Color online only.)
Methods and Materials

Pulse Echo and Photoacoustic Experimental Setup
Three severe combined immunodeficient (SCID) mice (R0, R1, R2) were implanted with window chambers. One side of the window chamber had a glass coverslip [referred to as the "coverslip side," Fig. 1(a) ], while the other side had exposed skin [referred to as the "skin side," Fig. 1(b) ]. PC-3 prostate tumor cells expressing green fluorescent protein (GFP) were implanted into the dorsal skin flap. The subsequent prostate tumor invasions were imaged using multiple modalities over the next four weeks, starting one week after the injection of tumor cells (conforming to protocol). Mice were cared for in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Arizona and maintained in a sterile clean-room facility in individual cages with controlled temperature and humidity. On imaging days, the mice were transported to the laboratory and anesthetized with an isoflurane flow system. A mouse was placed in a gas chamber, and 2% isoflurane was administered using O 2 with a flow rate of ∼1 l/min until the mouse was fully anesthetized. The mouse was then moved to the imaging setup, where a spherically focused 25-MHz ultrasound transducer (Olympus V324, Waltham, MA, f = 12.6 mm) was placed in a water tank facing the skin side of the mouse separated by a Tegaderm TM acoustic membrane. Hypoallergenic index matching gel (Parker Aquasonic Fairfield, NJ, USA; 100) was placed on the skin side of the window chamber to provide acoustic coupling. The mouse was mounted on a custom-built pad using the three screws, as displayed in Fig. 1(b) , to ensure accurate and consistent light delivery onto the window chamber. Anesthesia was maintained with ∼1% isoflurane, and Puralube R was placed over the eyes for protection. The body temperature of the mouse was maintained with a heating pad.
A schematic of the PA and PE imaging system is displayed in Fig. 2(a) . The 25-MHz focused transducer was connected to a pulser/receiver (Olympus Panametrics Waltham, MA, USA; 5900PR) and placed in a water bath over the mounted window chamber [ Fig. 2(b) ]. The transducer's focus was positioned between the coverslip and skin surface. The PA setup utilized a tunable pulsed laser source (Continuum Inc., Santa Clara, CA, USA; Surelite I-20, Continuum Inc., 5 ns, ∼20 mJ/pulse, tunable 680-1000 nm, 20 Hz) that was synchronized with the data-acquisition system and motor stages (Velmex, Inc. Bloomfield, NY, USA, B100). The laser light passed through a two-lens optical beam expander to increase the beam size to the diameter of the window chamber (12 mm). The beam was passed through a diffuser (not shown) before illuminating the coverslip. A single transmit pulse was synchronized with the laser firing in order to simultaneously capture the PA and PE signals (separated in real time by the one versus two-way travel of the acoustic wave for each modality). The transducer was raster scanned across the window chamber in both lateral dimensions to produce a 3-D data set of the tumor. In general, a rectangular region of interest (x ≈ 6 mm, y ≈ 14 mm) was scanned with spacing of x = 100 μm and y = 47.6 μm. The different spacing in the lateral directions is due to the continuous scanning along the y-axis and stepwise 
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Optical and Fluorescent Imaging Setup
Optical and fluorescent images of GFP were also captured using high resolution microscopy. Although optical imaging had a limited penetration depth, it provided a reference for comparison to the PE and PA images. A custom plastic holder was also used to fix the mouse using the screws on the window chamber, as depicted in Fig. 1(b) . In the same manner as mentioned earlier, mice were anesthetized and the window chamber was fastened to a holder on the microscope stage. Stage clips were used to secure the window chamber in the center of the microscope's field of view. Transillumination images were taken with white light incident on the skin flap. Additionally, fluorescent images of the GFP-expressing tumor cells were captured by illuminating the skin with 488-nm excitation.
Data Processing
The transducer was raster scanned across the window chamber collecting radio frequency (RF) data at each position (i.e., phase and magnitude). Each recorded signal was bandpass filtered between 15 and 30 MHz. The RF data were then demodulated with a Hilbert transform. For spectroscopic scans, the data were scaled to compensate for the wavelength-dependent laser energy output. Individual 2-D slices were then combined into a 3-D data set. A low-order median filter (3 pixels wide) followed by a Gaussian smoothing filter (3-5 pixels wide) were used to improve the signal-to-noise ratio.
As a means to calculate tumor growth using PE data, an automated volume-tracking algorithm utilizing image segmentation was developed, as illustrated in Fig. 3 . Each B-mode image was filtered and converted to a binary image using a 50%-ofmaximum threshold value. It was difficult to identify tissue interfaces in regions with small PE signals that produced weak boundaries. To compensate for this, each image was filtered with a binary dilation mask, broadening the tissue interface and ensuring a continuous boundary. An erosion filter, the same size and shape as the broadening mask, was then applied to restore the tissue boundary to the approximate original location. After a boundary was established, an automated contour-tracking algorithm was applied to determine the pixel locations of the skin surface and coverslip, which was assumed to be the lower boundary of the skin. The area between the coverslip and skin boundary was then calculated by summing the pixels between these boundaries and multiplying by the known pixel area. Finally, the effective volume of tissue was determined by applying the algorithm to multiple YZ planes while taking into account the appropriate interplane distance in the 3-D data set.
An image-segmentation algorithm was also developed to determine the size and track the growth of the fluorescing GFP tumor cells. A user-defined threshold value converted the original fluorescent image into a binary image such that only GFP pixels were thresholded high. The total number of GFP pixels was then calculated. Because the area of the window chamber was known, the area per pixel was used to determine the total number of thresholded pixels, yielding an estimate of the size of the fluorescing tumor.
Results and Discussion
Multimodality Imaging
There are several significant advantages to multimodality imaging because each technique yields different information regarding the tumor microenvironment. When combined with ultrasound imaging, other modalities such as photoacoustic and fluorescent imaging can be useful to further characterize the tumor environment and provide cross-modality comparison and validation.
Fluorescent and optical images of the GFP transfected tumors were used as a standard to track and compare the development of the tumor. A photograph of the coverslip with the associated fluorescent, PA, and PE images of mouse R2 is displayed in Fig. 5 . The photograph indicates that the tumor (middle of the red-scale box) is slightly darker than the surrounding healthy tissue. The fluorescent, PA, and PE images complement each other and reveal different sources of contrast related to the tumor environment. The transillumination fluorescent image portrays several blood vessels and the fluorescing tumor cells. The same blood vessels are resolved using PA imaging because blood has a higher optical absorption at 700 nm than surrounding tissue. 27 Whereas the optical and fluorescent images are 2-D projections of the tumor and surrounding tissue, the PA image provides depth information, so that the location of blood vessels can be imaged in three dimensions. The maximum intensity projection along the depth direction of the PA signal is presented in Fig. 5 . This perspective enables a direct comparison between the 3-D PA data and the 2-D fluorescent images. In the PA image, blood vessels are clearly detected and consistent with the vasculature depicted in the optical images. Additionally, the PA signal has the added benefit of mapping blood vessels deep under the skin surface (>1 cm), which cannot normally be resolved using such optical techniques as confocal microscopy and optical coherence tomography. 28 The PE image in Fig. 5 provides additional information regarding the physical characteristics of the tumor, such as size, shape, and echogenicity. This structural information supplements the information provided by the other modalities. In this example, the PE image (XY plane near top of the tumor) provides depth information not available in the fluorescent image and illustrates the tumor protruding outward toward the skin surface in the region of the GFP signal. The center of the tumor appears relatively homogeneous at this position. Thus, PA and PE imaging offer complementary contrast related to the cancerous microenvironment and vascular network during the tumor invasion. A dual-modality system capable of PA and PE imaging could be a valuable tool in the clinic for cancer diagnostics or monitoring therapy.
Combined Pulse Echo and Photoacoustic Imaging
Coregistered and superimposed PA (hot) and PE (gray) images are presented in Fig. 6 for mouse R2 on day 16. Figure 6 (c) depicts XY planes (from left to right), starting at the top of the tumor and progressing downward with a depth spacing of 240 μm. In the first image, the top of the tumor and window chamber border can be seen. Progressively deeper XY lateral planes show that the tumor appears to be reasonably circular, a claim that is validated by the skin-side photograph of the window chamber from Fig. 6(a) . Also, the tumor protrudes outward (away from the skin) slightly (≈700 μm) as estimated from the PE data from Fig. 6(d) .
The second image in Fig. 6 (c) displays the size of the tumor increasing downward and large fiducial ink mark placed on the skin (denoted with arrow). The ensuing planes inside the tumor reveal the 3-D vascular network. The blood vessels displayed in the PA image are well correlated with the photographs of the window chamber from Fig. 6 . Because PA imaging has better depth penetration than traditional optical techniques, the depth location of the blood vessels can be determined. For comparison, the YZ profile image of the tumor is depicted in Fig. 6(d) with the bracket indicating the range of lateral planes presented in Fig. 6(c) . Note that the fiducial mark placed on the skin is localized to the top of the skin and not visualized in deeper planes.
A series of optical and PE images from mouse R2 on day 23 are presented in Fig. 7 . The photographs in Figs. 7(a) and 7(b) reveal the circular shape of the tumor, which is consistent with the images from day 16 (see Fig. 6 ), except that the tumor has grown laterally. These optical images, however, provide minimal depth information. On the other hand, a sequence of PE images [Figs. 7(c) and 7(d)] demonstrates the imaging capability of 3-D high-resolution ultrasound for capturing depth information and characterizing the tumor structure, size, and echogenicity. Images reveal a bright, hyperechoic outer ring around the tumor, and a dark, hypoechoic tumor core. The reduced PE signal in the tumor's center, suggests a developing necrotic core, as commonly seen in cancerous tumors. 18, 29, 30 A dense fibrous outer ring has been previously associated with cancer progression. 18, 31 These images characterize the 3-D shape and size of the tumor as it protrudes outward away from the skin. By day 23, the tumor extended well beyond the original boundary of the skin by >2 mm.
On day 29, the tumor continued to protrude outward by approximately the same amount as the previous week (∼2 mm). However, the tumor's shape and overall profile had changed considerably. For instance, the left side of the window chamber developed a small tumor side lobe [ Fig. 8(d); left arrow] . A large portion of the necrotic core is hypoechoic, indicating a region of uniform density and low scattering, such as a localized region of fluid. 32, 33 In addition, the tumor of mouse R2 experienced a substantial hemorrhage in the final week of the study [ Fig. 8(a) ]. Because dried coagulated blood is a strong optical absorber, 34 we expected PA imaging to be able to map the hemorrhage. As displayed in both the photographs and PA images in Fig. 8 , the top of the tumor endured considerable hemorrhage. Despite light entering the window chamber through the coverslip, PA imaging was still able to detect the hemorrhage at the opposite side of the chamber near the skin surface with excellent signal-to-noise ratio (>20 dB). This illustrates that 3-D PA imaging has adequate depth penetration for imaging the entire extent of the window chamber. The strong PA signals in Fig. 8 are primarily due to the coagulated blood and fiducial ink mark. Hemorrhaging has previously been associated with prostate cancer. 32, 35 It is possible that the rigid coverslip and rapid growth of the prostate tumor-induced excessive stress at the skin surface, causing blood vessels to rupture. Alternatively, the hemorrhage may have also been caused by rapid angiogenesis and resulting collapse of the hemorrhage-prone blood vessels near the tumor. 
Photoacoustic Imaging During Cancer Progression
Photoacoustic imaging was used over the course of the study to monitor the 3-D optical absorption of the tumor microenvironment. The PA maximum intensity projections for mouse R2 are displayed in Fig. 9 . The PA images of the vascular network from days 9 and 16 are consistent with the optical images, but also provide additional depth information. For example, in the PA images on day 16, blood vessels were not visible in the skin-side photograph; however, these blood vessels were detected using PA imaging [ Fig. 9 ; small arrows]. There also appears to be an increase in vasculature growth near the center of the tumor from day 9 to 16. This suggests the presence of angiogenesis, which is commonly associated with prostate cancer progression. 37 Because in this study we did not measure blood volume fraction or molecular markers of angiogenesis, we can only speculate on neovascularization. On day 29, the PA signal is clearly dominated by the hemorrhage and ink mark placed on the skin of the mouse. Individual blood vessels are no longer visible, although the optical and maximum projection PA images are strongly correlated. Hemorrhaging is not unexpected in a tumor with a nutrient deficient core that is weak and necrotic. 33, [38] [39] [40] Thus, 3-D PA imaging of the tumor environment was consistent with the optical and fluorescent images and provided additional depth resolution [see Fig. 8(d) ].
Pulse Echo Imaging during Cancer Progression
The segmentation algorithm described in Sec. 2.3 was used to estimate the tumor size and growth rate based on fluorescent and PE images. The fluorescent images convey the distribution of GFP-expressing tumor cells. Although only 2-D projections, they represent the gold standard for determining size, shape, and growth rate specific to the tumor. Figure 10 (left) depicts the lateral growth of the tumor during three weeks or more of fluorescent imaging. Serial fluorescent images from one mouse are displayed in Fig. 10 (right) . Using the GFP thresholding algorithm, the area of each mouse tumor was calculated three times with seven-day intervals between fluorescent images. For each animal, average growth rates were calculated based on the slope of the best-fit line. Two mice (R1 and R2) exhibited a monotonic increase in tumor area with average respective growth rates of 2.02 and 0.75 mm 2 /day. The third tumor (R0) decreased slightly in size during the last week of the study, but still had an average growth rate of 0.52 mm 2 /day. Three-dimensional high-fresolution PE images were also analyzed to determine volumetric tissue growth. Results are summarized in Fig. 11 . It was assumed that most of the increase in volume was attributed to tumor growth or a resulting byproduct, such as edema or inflammation. 41 As expected, all three mice demonstrated a general increase in tissue volume over the course of the experiment, with average growth rates of 5.35, 7.32, and 3.37 mm 3 /day for mouse R0, R1, and R2, respectively. It should also be noted that all three mice exhibited a faster rate of tumor growth after day 16. Figure 11 (right) displays an example of tumor growth and proliferation based on PE images through the center of mouse R2's tumor. The smaller growth rate in R2's tumor from day 9 to 16 appeared to be in agreement with the tumor cross section from the associated days. The dramatic increase in tumor size between days 16 and 29 was also consistent with the associated depth profiles of the tumor. As with the fluorescent data, the tumor volume increased monotonically at all time points, except for mouse R0's tumor during the last week of imaging. This result was consistent with fluorescent imaging.
Normalized tumor growth based on fluorescent and PE image segmentation is plotted together in Fig. 12 with each data set scaled to its initial value. The linear correlation coefficients for the calculated tumor growth based on the PE and fluorescent images are also provided. Results from all three mice demonstrated significant positive correlation coefficients (R = 0.662, 0.990, 0.992). An average correlation coefficient (R = 0.97) and confidence interval (p < 0.01) were calculated using a Fisher z-transform and a bootstrapping algorithm with randomized shuffling (>1000) of the original data. 42, 43 It should be noted that the tumor's growth is impeded laterally by the window chamber and axially by the coverslip, and, thus growth was not expected to be uniform in all directions due to these boundary restrictions. Although direct comparisons between the lateral GFP distribution and tissue volume was difficult, this approach provided cross-validation between the tumor volume tracking results and those from the fluorescent images. For example, mouse R0 exhibited a reduction in both tumor area and volume over the last week of the study. Although this resulted in a reduced linear correlation coefficient (R = 0.662), both imaging approaches produced the same result, which added confidence to the measurement. There were several plausible explanations for the apparent decrease in tumor size. The optical and fluorescent images for mouse R0 indicated that it proliferated toward the edge of the window chamber, such that by day 29, it extended to the chamber boundary. Therefore, the tumor may have extended beyond the window chamber, so that the calculated volume was not accurate. This outcome could also be explained by the mouse's own immune system fighting off the tumor cells or reduced edema. 44 In general, the fluorescent area and tumor volume measurements are strongly correlated, both appearing to be acceptable methods for tracking tumor growth. Pulse echo imaging, however, provides additional depth information regarding tumor progression.
Photoacoustic Spectroscopy
Spectroscopic photoacoustic imaging enables noninvasive detection and mapping of the wavelength-dependent optical absorption of tissue and contrast agents. Because the optical absorption spectra of hemoglobin is highly dependent on the presence of oxygen, 19 PA spectroscopy can be used to detect relative and absolute levels of blood oxygen saturation. [45] [46] [47] [48] This can be useful in cancer imaging to distinguish veins from arteries or identify hypoxic regions near a tumor. 49, 50 In previous sections, we demonstrated that PA imaging was a valuable tool to identify and track blood vessels and hemorrhage in the tumor environment. We now revisit one data set and apply PA spectroscopy to characterize relative blood oxygen saturation in the imaged blood vessels. Because of slow scanning of the mechanical system, we limited PA spectroscopy to a single B-mode image at each laser wavelength (680-900 nm, λ = 25 nm). In this section, we calculated the slope of the best-fit line at each pixel between the PA signal magnitude and incident laser wavelength. 51, 52 The derivative of the PA signal is dependent on the localized optical absorption coefficient of the tissue and thus an indicator of a blood vessel's degree of oxygen saturation.
53 Figure 13 (a) demonstrates a series of PA images in the window chamber at multiple laser wavelengths. Figure 13 (c) represents a spectroscopic PA image, where the color (hot/cold) at each pixel denotes the sign and magnitude of the PA signal's Variation in blood oxygen saturation is a likely contributor to the different slopes. The PA slope at each pixel was determined from the best linear fit (see Fig. 14 for examples at regions A and B) . All images have dimensions of 10×4.5 mm.
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February 2011 r Vol. 16(2) 026012-7 slope between 680 and 900 nm. The magnitude of the slope is displayed on a decibel scale with a 30-dB dynamic range. Two small regions of interest are marked A and B for further analysis. Figure 13 (b) displays the PA signal at 800 nm (hot) superimposed on the coregistered PE image (gray). Figure 14 depicts the magnitude of the PA signal as a function of wavelength at two regions of interest indicated in Fig. 13(c) . The slope of the photoacoustic spectrum at region A is consistent with the absorption spectrum of deoxygenated hemoglobin, while the spectrum of region B is consistent with oxygenated hemoglobin. 19 However, there are other factors that might contribute to the wavelength dependence of the PA signal. For example, the PA signal is affected by laser fluence at each pixel location. Fluence depends primarily on the incident energy and illumination pattern, as well as the absorption and scattering coefficients spanning the complete optical path of all photons that reach that pixel location. Because the optical properties of the tissue were not known at each position inside the window chamber, Monte Carlo simulations could not be used to accurately estimate the magnitude of these effects at each wavelength. Instead, we used estimates of these contributing factors, revealing that these effects by themselves cannot explain the relative difference, nearly an order of magnitude that was observed in the spectroscopic PA signal between 680 and 900 nm. First, we used broad and diffuse light delivery through the coverslip such that the illumination pattern was similar entering the tissue at each wavelength. Second, our estimates of light loss due to scattering and attenuation differences in soft tissue were much smaller than the observed variation in the PA signal at each wavelength. For example, at 800 nm, blood has a much larger absorption coefficient (∼2.0 cm − 1 ) than surrounding tissue. 19, 48, 54 The attenuation coefficient of extravascular tissue (∼0.2 cm − 1 ) in the window chamber in the near infrared is at least an order of magnitude less. 55, 56 Given the diameter of a typical large blood vessel in the chamber (∼100 μm), this equates to a total attenuation of <2.0%. Moreover, the effect on the wavelength dependent absorption, as suggested by the slope calculation, was expected to be less. Combined with the small geometrical path difference between regions A and B of ∼500 μm, we are confident that the wavelength-dependent loss due to differences in the laser fluence at each pixel was <5%, far less than the observed difference in the wavelength-dependent slope of the PA signal. Therefore, while incremental light scattering and absorption of tissue unquestionably plays a role in the final absorption spectrum described by the spectroscopic PA signal, we estimated this effect to be minor compared to observed differences in the PA signal presented in Figs. 13 and 14 . This further supports PA spectroscopy as a tool for classifying blood vessels according to their oxygen content. This can be especially valuable for imaging prostate and other aggressive tumors that are often associated with hypoxic regions and reduced blood oxygen levels. [57] [58] [59] Thus, PA imaging and spectroscopy is not only a powerful technique for mapping the vascular network inside the window chamber, but also for monitoring blood oxygen saturation in the tumor microenvironment. PA spectroscopy can be extended to track absorbing contrast agents with high specificity. 26, 60, 61 
Future Considerations and Implications for Cancer Patients
The window chamber offers multimodality imaging in a wellcontrolled in vivo setting. This is an ideal environment to develop new imaging technology and targeted contrast agents for detecting molecular indicators for diagnostic and prognostic imaging of cancer. 26, [62] [63] [64] [65] The mouse window chamber model also enables testing novel cancer therapies using several modalities for comparison and cross-validation. First-stage screening of new drugs potentially accelerates their translation to cancer patients. The dual-modality system described in this study provides additional functionality and contrast for studying the tumor microenvironment using the window-chamber model. Photoacoustic imaging also overcomes penetration limits of traditional optical techniques. This suggests that an optimized PE and PA imaging system designed for humans might offer unique attributes for cancer imaging and monitoring therapy. Early clinical studies using PA for breast imaging demonstrate some of these advantages. 66, 67 The light delivery system employed in this study could be further adapted for reflection mode PA imaging using an in-line acoustic reflector with a single element 68 or clinical array transducer. 64 Such a handheld system would be capable of noninvasive imaging through the skin of humans (or small animals) for dual-modality PA and PE imaging of cancer growth, tumor vasculature, angiogenesis, and blood oxygen saturation. Combined with molecular contrast agents, a real-time PE and PA imaging system might aid in the diagnosis and prognosis of prostate and other types of cancer and provide feedback during therapy.
Conclusion
We described a novel, high-resolution, dual-modality imaging system that complements traditional approaches for tracking cancer progression using the mouse window-chamber model. The platform provides alternative sources of contrast and enhanced depth resolution compared to other techniques often applied to the window chamber model. Three-dimensional imaging of prostate tumor invasions revealed dramatic growth, blood vessels, and hemorrhaging several millimeters from the coverslip. These observations complemented fluorescent imaging of GFP in the window chamber. The combined platform is ideally suited for optimizing PA imaging and molecular contrast agents for advanced diagnosis and prognosis of prostate and other types of cancer. Translation of these technologies to the clinic could potentially have a profound impact on novel detection and treatment of prostate cancer.
